Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
Michelle better than a toothpaste
It's an investigational drug currently in Phase 3 clinical trials Eli Lilly's TRIUMPH Phase 3 program includes multiple trials for obesity, type 2 diabetes, NASH, and cardiovascular outcomes Expected timeline: FDA submission in 2026, potential approval in 20272028 Phase 2 results showed 24.2% weight loss at 48 weeks, the highest ever recorded for a GLP-1 class medication How to access now: Clinical trial enrollment (free), compounding pharmacies (with important legal caveats), or research peptides (grey market) When approved, retatrutide will be the first triple-agonist obesity medication (GLP-1 + GIP + glucagon) Is Retatrutide FDA Approved
Fast Absorbing Liquid Formula Quicker uptake than pills or powders
Call 833-424-9378
US$ 20.47
US$ 20.32
US$ 20.64
US$ 29.64
US$ 24.18
US$ 20.60
US$ 22.56
US$ 29.10
US$ 23.69
US$ 24.87
US$ 23.10
